Loading organizations...
DuPont Capital Management provides institutional asset management and comprehensive investment advisory services. The firm constructs and oversees diverse multi-asset class portfolios, strategically integrating alternative investments. Key capabilities include sophisticated asset allocation, diligent manager selection, and robust risk management, tailored for institutional capital.
Formally established in 1993, DuPont Capital Management originated from internally managing E. I. du Pont de Nemours and Company's corporate pension plan, a role begun in 1942. This extensive heritage in institutional capital oversight provided critical foundational expertise. The firm leveraged this proven internal capability, offering specialized asset management to a broader institutional investor base.
DuPont Capital Management primarily serves institutional investors, including corporate pension funds, endowments, and foundations. Its vision centers on disciplined capital preservation and long-term growth for these clients. The firm aims to be a trusted partner, navigating intricate investment landscapes through nuanced market understanding and tailored strategies for lasting value.
DuPont Capital Management has 2 tracked investments across 2 companies. The latest tracked deal is $15.0M Series D in uSamp in July 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 15, 2013 | uSamp | $15.0M Series D | Dupont Capital Management, Adam Marcus | — |
| Feb 10, 2012 | Noble Biomaterials | $8.0M Series B | Frances Kordyback | Robert Keith |